Fewer new drugs for rare disorders come to Canada relative to the US and Europe. Canada has set-up barriers that delay or deny access to new drugs for many patients with unmet or poorly met healthcare needs. This leaves vulnerable Canadians at a serious disadvantage.
This webinar will highlight how these barriers impact Canadians living with rare disorders, how the federal government made matters worse over the past six years with well-intentioned but poorly conceived plans to reduce drug prices, and why the result has been greater uncertainty and further delays. We will also discuss the impact of a proposed national pharmacare program and alternative ways to help ensure Canadians, especially those with rare disorders, have access to the drugs they need.
Event Details:
Please note, that all registered attendees will receive a post-event recording of the webinar. If you are unable to tune in live, you can watch the recording at your convenience.
Speakers
Register for this webinar below:
|
Thank you for Signing Up |
323 Chapel Street, Suite #300
Ottawa, Ontario, K1N 7Z2 Canada
613.482.8327
Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.
© 2023 Macdonald-Laurier Institute. All Rights reserved.